BTK and B-cell chronic lymphocytic leukemia: Here, we provide compelling evidence that the high expression of the UGT2B17 protein enhances the BCR-signaling capacity in B-CLL cells and promotes proliferation through functional interplay with several BCR effectors, including BTK, and with other activating signaling pathways, such as those triggered by cytokines.